“This shift along with policy pushes can drive demand for sustainable alternatives and help in growing the market for mycelium,” Aditya Srinivas Kandaala, founder of Roha Biotech, a startup ...

Biotech incubator Flagship Pioneering has uncorked its latest company. Lila Sciences is looking to use $200 million in seed funding to develop new advanced artificial intelligence that can power ...

An ambitious start-up embodies new optimism that artificial intelligence can turbocharge scientific discovery. An ambitious start-up embodies new optimism that artificial intelligence can ...

China has captured production of portions of the global biotechnology supply chain to accomplish President Xi Jinping’s goal to “develop effective deterrent against attempts by other countries ...

And like many other young players in the biotechnology business, this one's also still booking sizable losses, adding to investors' general disinterest. What this company lacks in size and profits ...

However, over the past two decades, the country has also invested in building a competitive biotechnology sector. Given its limited domestic market but strong infrastructure in manufacturing, research ...

A small Swiss biotech has ter­mi­nat­ed a mid-stage test of a new type of oral drug for peo­ple with Alzheimer’s dis­ease, ac­cord­ing to the fed­er­al … ...

In a sign it is willing to go further in responding to President Trump’s tariffs, Beijing blocked more American companies from importing goods into China. By Alexandra Stevenson Reporting from ...

First, let’s take a look at the private biotech investments in February 2025, breaking them down by value, location, funding type, and therapeutic subsector. In February 2025, Eikon Therapeutics ...

Before the Heubach acquisition, Sudarshan Chemical catered to global demand via its production units at Roha and Mahad in Maharashtra. Now, the company will have production facilities in 11 ...

Novo Nordisk has forged a deal with Gensaic, agreeing to pay up to $354 million per target to access technology for the tissue-selective delivery of molecules to cardiometabolic targets inside cells.

Expected readouts in diabetes, cancer and depression headline a series of study results that could help the biotechnology sector regain its footing after a shaky year. Over the past 10 years, ...